Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01806129 · ClinicalTrials.gov registry record · NA
Reproductive Health Program in Patients With Cancer
A NA study of Malignant Neoplasm, sponsored by ECOG-ACRIN Cancer Research Group.
- Active
- Registry status
- NA
- Development phase
- 434
- Enrollment target
- 20
- Study locations
NCT01806129: Active NA study of Malignant Neoplasm, sponsored by ECOG-ACRIN Cancer Research Group.
NCT01806129 is a NA study of Malignant Neoplasm that is active but no longer recruiting, run by ECOG-ACRIN Cancer Research Group. The registered enrollment target is 434 participants, below the 506-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (14% lower). The trial reports 20 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01806129, a NA study of Malignant Neoplasm, is active but no longer recruiting, sponsored by ECOG-ACRIN Cancer Research Group.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 434 participants
- Enrollment target
- 20
- Study locations
Study Summary
This clinical trial studies reproductive health program in patients with cancer. A reproductive health program may improve patients' understanding of reproductive risks and receipt of appropriate treatment to achieve their reproductive health goals.
Primary Outcome
Appropriate reproductive health management was determined using the followings: (1) Females that were pregnant or interested in immediate pregnancy (defined as within 1 year of enrollment) were given referral to obstetrician/gynecologist or counseled about pregnancy options (2) Females interested in future childbearing were counseled or given a referral for fertility preservation if requested (3) Females who were not interested in immediate pregnancy were given a referral or counseling to select
Conditions Studied
Interventions
- OTHER Standard practice related to reproductive heath
- OTHER Training modules, algorithm, referral development
Study Locations (20)
Hawaii
- Hawaii Cancer Care Inc-POB II - Honolulu
- Queen's Cancer Cenrer - POB I - Honolulu
- Queen's Medical Center - Honolulu
- Straub Clinic and Hospital - Honolulu
- University of Hawaii Cancer Center - Honolulu
- Queen's Cancer Center - Kuakini - Honolulu
- Kapiolani Medical Center for Women and Children - Honolulu
- Tripler Army Medical Center - Honolulu
- Pali Momi Medical Center - ‘Aiea
Colorado
- Rocky Mountain Cancer Centers-Aurora - Aurora
- Rocky Mountain Cancer Centers-Boulder - Boulder
- Cancer Center of Colorado at Sloan's Lake - Denver
- Rocky Mountain Cancer Centers-Sky Ridge - Lone Tree
- SCL Health Lutheran Medical Center - Wheat Ridge
Illinois
- John H Stroger Jr Hospital of Cook County - Chicago
- Carle on Vermilion - Danville
- Carle Physician Group-Effingham - Effingham
Georgia
- Augusta University Medical Center - Augusta
- John B Amos Cancer Center - Columbus
Arkansas
- Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro - Jonesboro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 434 participants |
| Start Date | 2016-09-02 |
| Est. Completion | 2025-12-30 |
| Phase | NA |
What the registry record for NCT01806129 still lists
NCT01806129 is an interventional study that assigns participants to a tested intervention. The registered 434 participants enrollment target is mid-sized for trials with a published cap, below the 506-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (14% lower).
The record links to 1 condition, with Malignant Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Standard practice related to reproductive heath is the first listed.
NCT01806129 names 20 study sites across 5 states, led by Hawaii, Colorado, Illinois.
Frequently Asked Questions
What is clinical trial NCT01806129 about?
NCT01806129 is a clinical study titled "Reproductive Health Program in Patients With Cancer". This clinical trial studies reproductive health program in patients with cancer. A reproductive health program may improve patients' understanding of reproductive risks and receipt of appropriate treatment to achieve their reproductive health goals.
What is the current status of trial NCT01806129?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 434 participants. The study started on 2016-09-02. Estimated completion is 2025-12-30.
What conditions does trial NCT01806129 study?
This clinical trial studies the following conditions: Malignant Neoplasm.
What interventions are being tested in trial NCT01806129?
The interventions under investigation include: Standard practice related to reproductive heath (OTHER), Training modules, algorithm, referral development (OTHER).
Who is sponsoring clinical trial NCT01806129?
This trial is sponsored by ECOG-ACRIN Cancer Research Group, which has 75 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01806129 being conducted?
This trial has 20 study locations across Arkansas, Colorado, Georgia, Hawaii, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01806129's enrollment target sits among peer trials
434 12th of 59 higher than 48 of 59 other Malignant Neoplasm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Malignant Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
RECRUITING · NA
-
Novel Outreach Methods to Increase Enrollment to Early Phase Clinical Trials
RECRUITING · NA
-
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
RECRUITING · NA
-
Decreasing Chemotherapy Induced Distress Using Immersive Virtual Reality in Patients With Cancer
RECRUITING · NA
-
A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant
RECRUITING · NA
-
Measuring Changes in Body Composition and Physical Function in Patients With Childhood Cancers
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04743245 · 434 participants · NA
Delivery SSO2 Therapy for 60 Min in Anterior MI Patients With PCI ≤ 6 Hours of Symptoms Onset Compared to Standard.
- NCT06471920 · 434 participants · NA
Improving Health for Patients With Chronic LBP in Rural Communities Through Telerehabilitation
- NCT07094113 · 434 participants · Phase 1
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
- NCT05563220 · 435 participants · Phase 1
Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI